Dr. Matthew S. Block, MD, PhD

Dr. Block practices at Mayo Clinic Breast Diagnostic Clinic in Rochester, Minnesota.

Dr. Block's NPI, 1356359111, was assigned on August 4, 2006. Dr. Block graduated from Mayo Clinic Alix School of Medicine - Rochester in 2005. Dr. Block holds Minnesota license 48572.

Dr. Block's primary practice is Mayo Clinic Breast Diagnostic Clinic, at 200 First Street SW, Rochester, MN 55905. The practice phone is (507) 284-5968.

Dr. Block's primary practice is Mayo Clinic Breast Diagnostic Clinic in Rochester, Minnesota. Dr. Block is also affiliated with Mayo Clinic Hospital, Saint Marys Campus. The medical group on file is Mayo Clinic. Dmand AI also links Dr. Block to 2 more hospitals, 1 clinical lab and 1 hospice, each named with a free account. Dr. Block's employer is on file too: a breast imaging center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Block practices, 6 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Block's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Block is board certified in internal medicine by the American Board of Internal Medicine. Dr. Block is licensed in Minnesota.

Dmand AI lists colorectal cancer and prostate cancer among the conditions Dr. Block treats.

CMS data shows 53,124 Medicare services from Dr. Block across 42 procedure codes in 2024, for 486 Medicare patients. Medicare paid $1,096,684 for them. Every service was in an office.

CMS counts 486 Medicare patients who saw Dr. Block in 2024. The largest group is 65 to 74, with 252 patients. 64% of them have high blood pressure, and 58% have high cholesterol. 6% are also on Medicaid. Their average risk score is 2.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Block's median patient age at 67, with 65% women.

In 2024, Dr. Block wrote 332 Medicare Part D claims for 59 patients. 55% of them were for generic drugs. CMS names the drug for 183 of them, across 8 drugs with 11 or more claims each, at $1,226,203 in total drug cost. In 2023, CMS named 139 claims across 7 drugs.

Dr. Block accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Block as offering telehealth.

Dmand AI links 117 papers to Dr. Block, published from 2011 to 2025. 2020 was the busiest year, with 12. The most frequent topics are Melanoma, Ovarian Neoplasms and Skin Neoplasms. Dr. Block has published most often in Gynecol Oncol. Dr. Block's most frequent co-authors are Svetomir N. Markovic, MD, Robert R. McWilliams, MD and Tina J. Hieken, MD.

Dmand AI links Dr. Block to 10 clinical trials, 5 of them phase 1 studies. 4 are still active or recruiting. Conditions studied include Fallopian Tube Diseases, Fallopian Tube Neoplasms and Melanoma. Mayo Clinic sponsors the most, 8.

CMS Open Payments shows 9 general payments to Dr. Block from 1 drug or device company from 2016 to 2022. Travel and lodging make up the largest share, 78% of the total. Merck Sharp & Dohme Corporation paid the most, $1,046.

Dr. Block graduated from Mayo Clinic Alix School of Medicine - Rochester in 2005. Dr. Block is a member of ACP.

Dr. Block is in network with 18 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.